Rigel Pharmaceuticals (RIGL) Amortizatization of Intangibles (2017 - 2026)

Rigel Pharmaceuticals' Amortizatization of Intangibles history runs 10 years deep, the most recent figure standing at $170000.0 for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 10.53% year-over-year to $170000.0; the TTM figure through Mar 2026 stood at $1.1 million (up 62.82% YoY), while the FY2025 annual figure was $1.2 million, up 62.2% from the prior year.
• Amortizatization of Intangibles was $170000.0 for Q1 2026 at Rigel Pharmaceuticals, down from $243000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $467000.0 in Q3 2025 to a low of -$79000.0 in Q2 2022.
• Historically, Amortizatization of Intangibles has averaged $151235.3 across 5 years, with a median of $170000.0 in 2026.
• The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles plunged 690.0% in 2022, then jumped 1266.67% in 2023.
• A 5-year view of Amortizatization of Intangibles shows it stood at $179000.0 in 2022, then soared by 45.25% to $260000.0 in 2023, then gained by 6.15% to $276000.0 in 2024, then declined by 11.96% to $243000.0 in 2025, then plunged by 30.04% to $170000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $170000.0 (Q1 2026), $243000.0 (Q4 2025), and $467000.0 (Q3 2025), per Business Quant data.